Download Financial Tear Sheet - Parexel Investor Relations

Financial Tear Sheet
Corporate Profile
PAREXEL International Corporation is a leading global biopharmaceutical services
company, providing a broad range of expert-based contract research, consulting, medical
communications, and technology solutions to the worldwide pharmaceutical,
biotechnology and medical device industries. Committed to providing solutions that
expedite time-to-market and peak-market penetration, PAREXEL has developed
significant expertise across the development and commercialization continuum, from drug
development and regulatory consulting to clinical pharmacology, clinical trials
management, medical education and reimbursement. PAREXEL Informatics, Inc. provides
advanced technology solutions, including medical imaging, to facilitate the clinical
development process.
Corporate Structure
The Company is managed through three business segments: Clinical Research Services
(CRS), PAREXEL Consulting Services, and PAREXEL Informatics (PI).
CRS constitutes the Company's core business and includes all phases of clinical research
from “first-in-man” trials, where a medicinal entity is tested on human subjects for the
first time, through post-marketing studies. CRS service offerings include clinical trials
management, observational studies, patient/disease registries and post-marketing
surveillance, data management and biostatistics, epidemiology and health
economics/outcomes research, clinical logistics, pharmacovigilance, and clinical
pharmacology, as well as related medical affairs, patient recruitment, and investigator
site services.
PAREXEL Consulting Services provides technical expertise and advice in such areas as
drug development, regulatory affairs, and good manufacturing practice (“GMP”)
compliance consulting. In addition, PC provides a full spectrum of market development,
product development, commercialization, and targeted communications services in
support of product launch. PC consultants also identify alternatives and propose
solutions to address clients’ product development, registration, and commercialization
issues.
PAREXEL Informatics provides information technology solutions designed to improve
clients’ product development processes. PI’s portfolio of products and services includes
ClinPhone RTSM, medical imaging services, RIM, CTMS, EDC, web-based portals, systems
integration, and patient diary applications. These solutions are sold individually or in
combination, as elements of an eClinical suite.
Page 1/3
Stock Quote
Stock Chart
PRXL (Common Stock)
Exchange
NASDAQ (US Dollar)
Price
$64.54
Change (%)
0.83 (1.27%)
Volume
797,829
52 Week Low
$51.16
Market Cap
$3,330,901,221
Rolling EPS
2.82
PE Ratio
23.1617
Shares Outstanding
50,954,585
Data provided by Nasdaq. Minimum 15
minutes delayed.
Data as of 05/03/17 4:00 p.m. ET
Recent Press Releases
Recent Events
May 03, 2017
PAREXEL International Reports Third
Quarter Fiscal Year 2017 Results
Thursday, June 30, 2016 9:00 a.m. ET
PAREXEL International Investor Day
2016
April 17, 2017
Parexel International Announces Date of
Third Quarter Fiscal Year 2017 Earnings
Release and Conference Call
April 03, 2017
PAREXEL Ranked a Top CRO in
CenterWatch Global Investigative Site
Relationship Survey
Thursday, May 4, 2017 10:00 a.m. ET
Q3 2017 PAREXEL International Earnings
Conference Call
Page 2/3
SEC Filings
Contact Information
Filing Date
Form
03/06/17
4
03/02/17
8-K
02/28/17
8-K
02/23/17
8-K
Ronald Aldridge
Sr. Director, Investor Relations
PAREXEL International Corporation
Phone: +1-781-434-4753
Email: [email protected]
Board of Directors
A. Dana Callow, Jr.
Managing General Partner
Boston Millennia Partners
Patrick J. Fortune, Ph.D.
Vice President Market Sectors
Partners HealthCare
Maykin Ho, Ph.D.
Managing Partner
Viridian Global
Eduard E. Holdener, M.D.
Chairman and Chief Executive Officer
NovImmune S.A.
Emeritus Head of Global Pharmaceutical Development
F. Hoffman-La Roche, Ltd.
Christopher J. Lindop
Chief Financial Officer
Quotient Limited
Richard L. Love
Managing Partner
Translational Accelerator, LLC (TRAC)
Josef H. von Rickenbach
Chairman of the Board and Chief Executive Officer
PAREXEL International Corporation
Ellen M. Zane
CEO Emeritus
Vice Chair, Board of Trustees
Tufts Medical Center
Page 3/3